Blue Jet Healthcare Limited has informed the Exchange about Capacity addition
BLUEJET · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 2.0 pts more than Nifty Smallcap 250 and 2.0 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
The Board of Blue Jet Healthcare has approved the acquisition of a 102.48-acre industrial land parcel at the Rambilli Industrial Park, Anakapalli District, Andhra Pradesh, allotted by APIIC. The land cost is approximately ₹41.87 crore. The company plans a greenfield manufacturing facility on this land as part of its long-term capacity expansion. Phase I capital investment is estimated at up to ₹1,000 crore, to be deployed in a modular manner, with capacity addition of up to 1,000 KL (scalable in later phases). The new facility is targeted to be commissioned by FY 28-29, and financing will be through a mix of internal accruals, equity, and debt. The expansion is aimed at supporting growth, entering new product verticals, and deepening strategic customer relationships.
This is a major capacity expansion announcement, signaling strong growth ambitions but also significant capital outlay over the next 3-4 years. Shareholders should expect a potential mix of equity dilution and debt raise to fund the ₹1,000 crore Phase I investment, with execution risk extending until FY 28-29 commissioning. Positive for long-term growth narrative; near-term stock reaction may depend on funding clarity.